Name: World Pharma Pricing Market Access & Evidence Congress 2020
Start: 2020-09-24T08:30
End: 2020-09-25T17:00
Location: Virtual

24 - 25 September 2020 | LIVE

World Leading Biopharma Pricing, Access and Evidence Congress

DOWNLOAD LATEST AGENDA

BOOK TICKETS NOW & SAVE

ENQUIRE TO SPONSOR NOW

Sign Up for Event Updates

PPMA & Evidence congress IS GOING VIRTUAL FOR 2020!

The Pricing, Market Access and Evidence Congress arrives at a time of unprecedented disruption.

Therefore, Terrapinn will provide a digital venue that serves as a forum for information exchange and bring together key stakeholders from pharma/biotech, HTAs, Payers and solution providers.

There’s never been a better time for the life science community to connect, collaborate and share ideas.

Until we meet again in person, our commitment is to deliver this by using the most innovative digital tools in the most innovative way.

Join us.

BOOK TICKETS NOW & SAVE

Thomas Mueller

Head of Directorate General 1 "Drugs Medical Devices Biotechnology"

Federal Ministry of Health for Germany

Caridad Pontes

Manager of Pharmacotherapeutic Harmonization

Catalan Health Service

Carla Deakin

Programme Director – Commercial & Managed Accesss

NICE

Marcus Guardian

Chief Operating Officer

National Health Care Institute (Zorginstituut Nederland)

Navin Joshi

Global Head of Pricing & Access Capabilities

GlaxoSmithKline

Bharat Twearie at World Pharma Pricing and Market Access

Bharat Tewarie

Executive Vice President and Chief Marketing Officer

UCB

Anne Marciniak at World Pharma Pricing and Market Access

Gavin Lewis

Vice President for Value, Access and Policy

Amgen

Wills Hughes-Wilson

Head of Patient Access & Commercial Planning

Mereo Biopharma

Stefn Holmstrom at World Pharma Pricing and Market Access

Stefan Holmstrom

Head, HTA Strategy and PRO excellence

Astellas

Claudia Neuber

Head of Global Pricing Implementation, Global Market Access and Pricing

AstraZeneca

Tamir Singer

Head of Commercial Development, Specialized Commissioning

NHS England

Sheela Upadhyaya

Associate Director Highly Specialised Technologies, Centre for Health Technology Evaluation

NICE

Sofie Alverlind

Project Manager

Swedish Association of Local Authorities and Regions

Elena Lungu

Manager Of Policy Development, Patented Medicine Prices Review Board

Govenment of Canada

Oresta Piniazhko

Director, HTA Department, State Expert Centre and Member, Expert Committee

Ministry of Health of Ukraine

Inez Naidu

Head - Discovery Health Medicines Unit

Discovery Health

Ulf Staginnus

Senior Vice President, Head Global Market Access & Pricing

Ipsen

Diane Munch

VP, Global Pricing, Patient & Health Impact

Pfizer

Anne Marciniak

Head of Market Access, Europe

Aimmune

Sarah Pitluck

Head, Global Pricing And Reimbursement

Spark Therapeutics

Martin Price

Vice President, Health Economics, Market Access & Reimbursement

Janssen

Timothy Lenehan

Senior Director - Global Value and Access

Biogen

Endel Gottfried

EBM, HTA Team Leadersearch

HVB Ö SV

Goedele van Haasteren

Staff Member

Ministry of Health of Switzerland

Evert Jan van Lente

Director EU-Affairs, AOK-Bundesverband and Chair

Norwegian Medicines Agency

Head of Contracting Innovation, Global Market Access

Sanofi

Cristina Martin-Rinconada at World Pharma Pricing and Market Access

Angelina Irizari Policarpio

Head of HEOR and Real World Evidence Communications

Market Access Strategy Leader

Bayer

Ramon Hernandez Vecino

Head of Real World Evidence Data & Analytics Engagement Lead R&D

Sanofi

Kevin Loth

Vice President, Corporate Affairs and Policy, Worldwide Markets

Celegene

Andres Pichon-Riviere

Executive Director

Institute for Clinical Effectiveness and Health Policy (IECS)

Kagan Atikeler

Pharmacist

Turkish Medicines and Medical Devices Agency

Anne Willemson at World Pharma Pricing and Market Access

Anne Willemsen

Project Manager EUnetHTA,

National Health Care Institute (ZIN).

Stephen Hall

Knowledge Exchange Associate

NIHR Innovation Observatory

Kart Veliste at World Pharma Pricing and Market Access

Kärt Veliste

Chief Specialist at Department of Medicines and Medical Devices

Estonian Health Insurance Fund

Bart Vermeulen

Deputy Director Healthcare At Office Of The Minister Of Social Affairs And Public Health

Belgian Federal Government

Oliver Gassner

Head Digital Health Intelligence Europe, EMEA

Bayer

Lisette Kaskens

Senior Global Market Access Manager

Advanced Accelerator Applications

David Thompson

Senior Vice President, Head Of Thought Leadership, Real World And Late Phase Research

Syneos Health

Bart Van den Daele

Head of External Affairs – Director Market Acces

Gilead

Cristina Martin-Rinconada

Head of Value & Access for International Partners Markets (MENA & CEER Regions)

Biogen

Martine Zimmerman n

Global Head of Regulatory Affairs

Alexion Pharma

Marco Marchetti

Director Of The National Center For Health Technology Assessment

Istituto Superiore di Sanita

Niri Bhimsan

Head of Health Technology Assessment

Discovery Health

Francis Arickx

Advisor General, Head of Directorate, Directorate Pharmaceutical Policy

National Institute for Health and Disability Insurance (RIZIV INAMI)

Charles-Etienne de Cidrac

Director, Health

AXA

Giovanni Tafuri

EUnetHTA, Senior Scientific Officer

National Health Care Institute (ZIN)

Detlev Parow

Head of Department of Medicines, Therapeutic Appliances and Remedies

Head Ethics & Compliance, Europe & Canada

Takeda

Enkeleida Nikai

Head of Real World Evidence

Janssen

Julie Locklear

Head of Global Health Economics & Outcomes Research

Argenx

Omar Dabbous

Vice President of Global HEOR and RWEs

Avexis

Sandro Cesaro

Head Pricing I8 & Product Pricing Strategies

Head of Section - Business Intelligence and Health Economy

Amgros

Alexander Natz

Secretary General

European Confederation of Pharmaceutical Entrepreneurs

Ion Agirrezabal

Senior Consultant, Health Econ and Outcomes Res Md

Covance

Kamilla Gaitova

Head of HTA Department, Republican Center for Health Development

Kazakhstan

Nuriya Musina

Head of Development, Center of Healthcare Quality Assessment and Control

Ministry of Health of the Russian Federation

Michael Müller

Head of Market Access, Western Europe

Sun Pharma

Erik van den Berg

Chief Executive Officer

Head of Global Market Access

Hansa Biopharma

Shanthy Krishnarajah

Sr. Director, Market Access and Strategy

How does it work?

International Speakers

100+ speakers from across Europe, USA, Asia, South America and many other markets will share their insights and knowledge through broadcasted presentations and live discussions. Many of whom are senior representatives from pharma/biotechs, HTAs and Payers

Live panel discussions

We have curated panels of industry experts to debate some of your burning questions. You’ll be able to watch them live, pose questions to the panel and watch later on-demand

Virtual roundtables

This is where it gets really interactive. Join a virtual roundtable on a topic of your choice, then virtually meet, discuss and network with operators facing the same issues.

Meet (virtually) face to face

Virtual meetings have become the new norm. You can select those you’d like to meet from the list of registered participants. We’ll then set up and host a virtual meeting with you and your selected participants.